Project Grant R21AI193280

Award Date 7/8/25
Completion Date 7/7/27
Dollars Obligated $439K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $149,528 to The Johns Hopkins University to conduct research on the mechanisms underlying sex differences in vaccine-induced immunity. The research aims to investigate how estrogen receptor signaling and mTOR activation in B cells influence metabolic processes and contribute to greater antibody...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), provides $207,170 to Harvard Medical School to conduct research on sex differences in T cell metabolism. The key objectives are to: 1) assess sex differences in T cell function and metabolism, and 2) investigate the contributions of sex hormones versus sex chromosomes to these differences in the context of viral...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to elucidate the molecular mechanisms underlying T cell dysfunction and HIV persistence in persons with HIV (PWH). The $500,000 award, effective from September 1, 2024 to August 31, 2029, will support research conducted by The General Hospital Corporation (Massachusetts General Hospital) to identify and...
This Project Grant award from the National Institute on Aging (NIA) under CFDA 93.866 - Aging Research supports a research study to determine how biological sex influences the self-renewal of B1 cells, a subset of B cells that produce natural antibodies, in aged mice and humans. The goal is to elucidate the mechanisms behind differential B1 cell self-renewal in aged males versus aged females, which could inform strategies to maintain healthy natural immunity into old age. The $1,526,780 award,...
This $112,956 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at Texas A&M University System Health Science Center to study how biological sex impacts innate immune and metabolic responses that influence infection susceptibility. The award aims to leverage the Drosophila melanogaster genetic model to assess the impact of post-mating reproductive changes in females, but not males,...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Program (CFDA 93.855) provides $1,172,336.00 to the University of Massachusetts Medical School over a 5-year period starting on August 19, 2024. The goal of the research is to investigate how distinct age-associated B cell subsets can protect the aged from influenza. Specifically, the project will determine the potential of different...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $489,500.00 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to conduct research on overcoming technical obstacles in understanding the assembly and regulation of B cell antigen receptors (BCRs). The research aims to elucidate the structural details of BCR assembly and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $242,310 to Emory University to study how genetic diversity in the immunoglobulin heavy chain locus impacts the development of neutralizing antibodies against the HIV envelope protein. The project aims to: 1) Identify polymorphisms in rhesus macaques vaccinated with the BG505 SOSIP.664 HIV immunogen that are associated with differential...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $318,085 to support research on the role of antibodies in controlling virus infections through Fc-dependent mechanisms such as antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytolysis (CDC). The research aims to elucidate the...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $130,368 to President and Fellows of Harvard College, doing business as Harvard Medical School, to define how B cell receptor binding site copy number is developmentally regulated to optimize antigen recognition and support affinity-driven antibody selection within B cell germinal centers. The research aims to...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Grant Program (CFDA 93.855), provides $439,088 to The General Hospital Corporation (Massachusetts General Hospital) to mechanistically define how sex differences in hormones and circulating cytokines modulate B cell class switch recombination, a core immune reaction underlying humoral immunity. The research aims to rigorously elucidate a new mechanism for sex-based control over antibody production, which is foundational to humoral immunity and vaccine design. The award has a project period from July 8, 2025 to July 7, 2027.

Generated 8/5/25, 6:20 AM